Brigit Biofarmaka Teknologi Tbk. vs Pudjiadi & Sons Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp254 (market cap 172.82B, 592.2K 24h volume), while Pudjiadi & Sons Tbk. trades at Rp500 (market cap 390.93B, 6.9K 24h volume). The key difference: Pudjiadi & Sons Tbk. is far larger — about 2.3× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Brigit Biofarmaka Teknologi Tbk. is more actively traded (592.2K versus 6.9K). Which is the better fit depends on your goals.
| OBAT | PNSE | |
|---|---|---|
Market Cap | 172.82B | 390.93B |
Volume | 592.2K | 6.9K |
Lot | 5.92K | 69 |
Turnover | 147.05M | 3.47M |
Average Price | 248.31 | 502.22 |
Value | 147.05M | 3.47M |
Indicative Equilibrium Price | 254 | 505 |
Indicative Equilibrium Volume | 10 | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →PT Pudjiadi and Sons Tbk was established based on Notarial Deed No. 34 dated December 17, 1970 of Ridwan Suselo, s.h., notaris in Jakarta. Hotel business with all the facilities and infrastructures, such as , accommodation, office, shopping mall, apartment, recreation place and entertainment in the location of hotel. The Company is the owner of Jayakarta Hotel, a four star hotel.
Read more on PNSE →